Sökning: onr:"swepub:oai:gup.ub.gu.se/295295" > Liver nucleotide bi...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07616naa a2200733 4500 | |
001 | oai:gup.ub.gu.se/295295 | |
003 | SwePub | |
008 | 240528s2020 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:umu-173919 | |
009 | oai:lup.lub.lu.se:d90c4873-8fd4-45ad-8588-1b2935544706 | |
009 | oai:prod.swepub.kib.ki.se:144265286 | |
024 | 7 | a https://gup.ub.gu.se/publication/2952952 URI |
024 | 7 | a https://doi.org/10.1038/s41598-020-68130-y2 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1739192 URI |
024 | 7 | a https://lup.lub.lu.se/record/d90c4873-8fd4-45ad-8588-1b29355447062 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1442652862 URI |
040 | a (SwePub)gud (SwePub)umud (SwePub)lud (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Jain, Ruchiu Lund University,Lunds universitet,Diabetes - öpatofysiologi,Forskargrupper vid Lunds universitet,Diabetes - Islet Patophysiology,Lund University Research Groups4 aut0 (Swepub:lu)med-ruj |
245 | 1 0 | a Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes |
264 | c 2020-07-14 | |
264 | 1 | b Springer Science and Business Media LLC,c 2020 |
520 | a Identification of biomarkers associated with protection from developing diabetic complications is a prerequisite for an effective prevention and treatment. The aim of the present study was to identify clinical and plasma metabolite markers associated with freedom from vascular complications in people with very long duration of type 1 diabetes (T1D). Individuals with T1D, who despite having longer than 30 years of diabetes duration never developed major macro- or microvascular complications (non-progressors; NP) were compared with those who developed vascular complications within 25 years from diabetes onset (rapid progressors; RP) in the Scandinavian PROLONG (n = 385) and DIALONG (n = 71) cohorts. The DIALONG study also included 75 healthy controls. Plasma metabolites were measured using gas and/or liquid chromatography coupled to mass spectrometry. Lower hepatic fatty liver indices were significant common feature characterized NPs in both studies. Higher insulin sensitivity and residual beta-cell function (C-peptide) were also associated with NPs in PROLONG. Protection from diabetic complications was associated with lower levels of the glycolytic metabolite pyruvate and APOCIII in PROLONG, and with lower levels of thiamine monophosphate and erythritol, a cofactor and intermediate product in the pentose phosphate pathway as well as higher phenylalanine, glycine and serine in DIALONG. Furthermore, T1D individuals showed elevated levels of picolinic acid as compared to the healthy individuals. The present findings suggest a potential beneficial shunting of glycolytic substrates towards the pentose phosphate and one carbon metabolism pathways to promote nucleotide biosynthesis in the liver. These processes might be linked to higher insulin sensitivity and lower liver fat content, and might represent a mechanism for protection from vascular complications in individuals with long-term T1D. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
700 | 1 | a Ozgumus, T.u University of Bergen4 aut |
700 | 1 | a Jensen, T. M.u University of Southern Denmark,Steno Diabetes Center Copenhagen4 aut |
700 | 1 | a du Plessis, E.u University of Bergen4 aut |
700 | 1 | a Keindl, M.u University of Bergen4 aut |
700 | 1 | a Moller, C. L.u Steno Diabetes Center Copenhagen4 aut |
700 | 1 | a Falhammar, H.u Karolinska Institutet4 aut |
700 | 1 | a Nystrom, T.u Karolinska Institutet,Stockholm South General Hospital4 aut |
700 | 1 | a Catrina, S. B.u Karolinska Institutet,Akademiskt specialistcentrum, Stockholm,Karolinska University Hospital4 aut |
700 | 1 | a Jorneskog, G.u Karolinska Institutet,Danderyd Hospital4 aut |
700 | 1 | a Jessen, L. E.u Technical University of Denmark4 aut |
700 | 1 | a Forsblom, C.u Folkhälsan Research Center,University of Helsinki,Helsinki University Central Hospital4 aut |
700 | 1 | a Haukka, J. K.u Helsinki University Central Hospital,Helsinki University of Technology,Folkhälsan Research Center4 aut |
700 | 1 | a Groop, P. H.u Monash University,Folkhälsan Research Center,University of Helsinki,Helsinki University Central Hospital4 aut |
700 | 1 | a Rossing, P.u University of Copenhagen,Steno Diabetes Center Copenhagen4 aut |
700 | 1 | a Groop, Leifu Lund University,Lunds universitet,Genomik, diabetes och endokrinologi,Forskargrupper vid Lunds universitet,Genomics, Diabetes and Endocrinology,Lund University Research Groups,University of Helsinki,Institute for Molecular Medicine Finland (FIMM)4 aut0 (Swepub:lu)endo-lgr |
700 | 1 | a Eliasson, Matsu Umeå University,Umeå universitet,Avdelningen för medicin4 aut0 (Swepub:umu)mael0021 |
700 | 1 | a Eliasson, Björn,d 1959u University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xelibj |
700 | 1 | a Brismar, K.u Karolinska Institutet,Karolinska University Hospital4 aut |
700 | 1 | a Al-Majdoub, Mahmoudu Lund University,Lunds universitet,Diabetes - molekylär metabolism,Forskargrupper vid Lunds universitet,Diabetes - Molecular Metabolism,Lund University Research Groups4 aut0 (Swepub:lu)med-ma22 |
700 | 1 | a Nilsson, Peter M.u Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)medf-pni |
700 | 1 | a Taskinen, M. R.u University of Helsinki4 aut |
700 | 1 | a Ferrannini, E.u CNR Institute of Clinical Physiology (IFC-CNR)4 aut |
700 | 1 | a Spégel, Peteru Lund University,Lunds universitet,Centrum för analys och syntes,Kemiska institutionen,Institutioner vid LTH,Lunds Tekniska Högskola,Centre for Analysis and Synthesis,Department of Chemistry,Departments at LTH,Faculty of Engineering, LTH4 aut0 (Swepub:lu)tekn-psp |
700 | 1 | a Berg, T. J.u University of Oslo,Oslo university hospital4 aut |
700 | 1 | a Lyssenko, Valeriyau Lund University,Lunds universitet,Genomik, diabetes och endokrinologi,Forskargrupper vid Lunds universitet,Genomics, Diabetes and Endocrinology,Lund University Research Groups,University of Bergen4 aut0 (Swepub:lu)endo-vly |
710 | 2 | a Diabetes - öpatofysiologib Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Scientific Reportsd : Springer Science and Business Media LLCg 10:1q 10:1x 2045-2322 |
856 | 4 | u https://www.nature.com/articles/s41598-020-68130-y.pdf |
856 | 4 | u https://doi.org/10.1038/s41598-020-68130-yy Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1456686/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u http://dx.doi.org/10.1038/s41598-020-68130-yx freey FULLTEXT |
856 | 4 8 | u https://gup.ub.gu.se/publication/295295 |
856 | 4 8 | u https://doi.org/10.1038/s41598-020-68130-y |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-173919 |
856 | 4 8 | u https://lup.lub.lu.se/record/d90c4873-8fd4-45ad-8588-1b2935544706 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:144265286 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.